Trial Profile
Phase I/II Study of Escalating Doses of Taxol Used Concurrently With Ethyol and Accelerated Hyperfractionated Radiotherapy in the Treatment of Stage III and IV Carcinoma of the Head and Neck.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 Dec 2012
Price :
$35
*
At a glance
- Drugs Amifostine (Primary) ; Paclitaxel
- Indications Head and neck cancer
- Focus Adverse reactions
- 29 May 2009 New trial record